Clinical Trials Logo

Stuttering clinical trials

View clinical trials related to Stuttering.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05641701 Not yet recruiting - Clinical trials for Childhood-Onset Fluency Disorder (Stuttering)

Stimulation of the Thalamus to Ameliorate Persistent Disfluency

SToPeD
Start date: November 1, 2023
Phase: N/A
Study type: Interventional

Persistent developmental stutter / childhood onset fluency disorder is a disabling condition leading to significant communication and psychological disability. Established treatment consists of intensive speech therapy, and whilst initially effective, has a waning long-term benefit. Our research team aims to provide evidence of stutter management by addressing the primary neurological issue in this disorder using Deep Brain Stimulation. The investigators propose to perform bilateral DBS on 3 participants with stutter refractory to intensive speech therapy, to determine a response in their stutter. The assessments will be double-blinded. The investigators will use the outcome of this small pilot study to determine the feasibility and details of a larger randomized controlled trial.

NCT ID: NCT05640440 Not yet recruiting - Clinical trials for Executive Dysfunction

Executive Function Performance in Children Who Stutter

Start date: December 1, 2022
Phase:
Study type: Observational

The study aims to asses the executive function in children who stutter for better management of those children

NCT ID: NCT05437627 Not yet recruiting - Stuttering Clinical Trials

Computerized Based Analysis for Detection and Severity Assessment of Stuttering

Start date: September 1, 2022
Phase:
Study type: Observational [Patient Registry]

In the light of previous attempts to design and develop automated and objective measures for automatic speech recognition system that detects disfluent speech and assess its severity, yet fully automated measurement of stuttered speech is not available. This study was triggered by the need to design and develop a simple and reliable computerized tool for identification of stuttering and measurement for its severity. Therefore, the aim of this study is to develop a user interface that can work on windows system for the adopted stuttering recognition model which can be used in clinical practice by physicians and therapists.

NCT ID: NCT05437159 Not yet recruiting - Clinical trials for Stuttering, Developmental

Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech

Start date: March 2023
Phase: N/A
Study type: Interventional

Persistent developmental stuttering affects more than three million people in the United States, and it can have profound adverse effects on quality of life. Despite its prevalence and negative impact, stuttering has resisted explanation and effective treatment, due in large part to a poor understanding of the neural processing impairments underlying the disorder. The overall goal of this study is to improve understanding of the brain mechanisms involved in speech motor planning and how these are disrupted in neurogenic speech disorders, like stuttering. The investigators will do this through an integrated combination of experiments that involve speech production, functional MRI, and non-invasive brain stimulation. The study is designed to test hypotheses regarding the brain processes involved in learning and initiating new speech sound sequences and how those processes compare in persons with persistent developmental stuttering and those with typical speech development. These processes will be studied in both adults and children. Additionally, these processes will be investigated in patients with neurodegenerative speech disorders (primary progressive aphasia) to further inform the investigators understanding of the neural mechanisms that support speech motor sequence learning. Together these experiments will result in an improved account of the brain mechanisms underlying speech production in fluent speakers and individuals who stutter, thereby paving the way for the development of new therapies and technologies for addressing this disorder.

NCT ID: NCT05383430 Not yet recruiting - Clinical trials for ADHD Children With Stuttering

Prevalence of Stuttering in Children With ADHD at Sohag University Hospital

Start date: June 2022
Phase:
Study type: Observational

The majority of the latest research suggests that stuttering is associated with significantly elevated levels of trait and social anxiety. The prevalence of children who stutter and have attention deficit/ hyperactivity disorder (ADHD) ranges from 4 to 26%. About 10-20% of children who stutter might show ADHD. Gender ( male) is the dominant risk factor for stuttering, as also applies to other neurodevelopmental disorders. Examples include attention deficit hyperactive disorder (ADHD), conduct disorder, tics and the Gilles de la Tourette syndrome (GTS). These neurodevelopmental disorders are the second -most prominent set of comorbidities with stuttering. Attention-deficit hyperactivity disorder (ADHD) and stuttering share many characteristics in addition to temperament . A complex interplay of neural differences, with genetic and environmental components, has been reported as a possible cause of both disorders. In addition, both may appear more frequently in boys than in girls . Furthermore, it is emphasized that childhood stuttering can be accompanied by aspects of ADHD . Likewise, children exhibiting signs of ADHD more frequently display speech disfluencies than their peers. It is suggested that children with stuttering and those without stuttering will display different profiles in terms of temperament, certain aspects of ADHD, and some types of anxiety. In addition, it is to be expected that there will be some correlations between these variables in children who stutter. However, it is not possible to draw definite conclusions about this issue that could be generalized to all children who stutter. Furthermore, there are very few studies that deal with combinations of these variables .

NCT ID: NCT05291572 Not yet recruiting - Clinical trials for Stuttering, Childhood

Comparative Study Between Three Different Methods for Stuttering Therapy in Children

Start date: April 2022
Phase: Phase 4
Study type: Interventional

The aim of work is comparing between three different methods for treatment of stuttering in children in order to reach to the best method for treatment

NCT ID: NCT04412213 Not yet recruiting - Clinical trials for Stuttering, Childhood

Correlation of Family History, Age at Onset & Severity of Stuttering

Start date: June 2020
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to Detect the influence of the family history of stuttering (distance of relative) on the onset and severity of stuttering in children in these families. Also to explore developmental differences among young stutterers.